Biolife Solutions (BLFS) Total Non-Current Liabilities (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Total Non-Current Liabilities of $28.5 million for Q1 2026, down 15.76% quarter-over-quarter from $33.8 million in Q4 2025.
Biolife Solutions (BLFS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Total Non-Current Liabilities for 15 consecutive years, with $28.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $28.5 million; the TTM figure through Mar 2026 stood at $28.5 million (changed N/A YoY), while the FY2025 annual figure was $33.8 million, down 33.12% from the prior year.
- Total Non-Current Liabilities eased to $28.5 million in Q1 2026 per BLFS's latest filing, from $33.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $88.4 million in Q1 2023 and bottomed at $28.5 million in Q1 2026.
- Historically, Total Non-Current Liabilities has averaged $66.1 million across 5 years, with a median of $75.1 million in 2023.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 125.1% — and 2025, when it sank 33.12%.
- Biolife Solutions' Total Non-Current Liabilities stood at $83.7 million in 2022, then fell by 10.36% to $75.1 million in 2023, then sank by 32.61% to $50.6 million in 2024, then plunged by 33.12% to $33.8 million in 2025, then dropped by 15.76% to $28.5 million in 2026.
- Business Quant data shows BLFS's Total Non-Current Liabilities at $28.5 million in Q1 2026, $33.8 million in Q4 2025, and $50.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.49 Bn | 129.27 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.56 Bn | 51.70 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.74 Bn | 34.38 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.74 Bn | 32.27 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.15 Bn | 26.47 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.03 Bn | 24.59 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.41 Bn | 15.01 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.79 Bn | 14.66 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.59 Bn | 11.44 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Biolife Solutions | 1.81 Bn | 1.73 Bn | 18.29 Mn | 27.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.09 Mn |
| Mar 31, 2026 | 28.49 Mn |
| Dec 31, 2025 | 33.83 Mn |
| Dec 31, 2024 | 50.58 Mn |
| Dec 31, 2023 | 75.05 Mn |
| Sep 30, 2023 | 78.77 Mn |
| Jun 30, 2023 | 79.14 Mn |
| Mar 31, 2023 | 88.36 Mn |
| Dec 31, 2022 | 83.72 Mn |
| Sep 30, 2022 | 79.71 Mn |
| Jun 30, 2022 | 61.04 Mn |
| Mar 31, 2022 | 68.13 Mn |
| Dec 31, 2021 | 76.20 Mn |
| Sep 30, 2021 | 64.61 Mn |
| Jun 30, 2021 | 63.16 Mn |
| Mar 31, 2021 | 30.27 Mn |
| Dec 31, 2020 | 29.51 Mn |
| Sep 30, 2020 | 8.77 Mn |
| Jun 30, 2020 | 7.74 Mn |
| Mar 31, 2020 | 25.38 Mn |